N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143029 |
| CAS No | NA |
| Mol.F. | C10H10N2O4 |
| Mol.Wt. | 222.20 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143030 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143031 |
| CAS No | NA |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143032 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143033 |
| CAS No | NA |
| Mol.F. | C14H21N3O2 |
| Mol.Wt. | 263.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143034 |
| CAS No | NA |
| Mol.F. | C14H20N4O4 |
| Mol.Wt. | 308.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143035 |
| CAS No | NA |
| Mol.F. | C13H17N3O4 |
| Mol.Wt. | 279.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143036 |
| CAS No | NA |
| Mol.F. | C13H17N3O4 |
| Mol.Wt. | 279.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143037 |
| CAS No | NA |
| Mol.F. | C14H17N3O5 |
| Mol.Wt. | 307.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143038 |
| CAS No | NA |
| Mol.F. | C14H19N3O4 |
| Mol.Wt. | 293.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143039 |
| CAS No | NA |
| Mol.F. | C11H15N3O3 |
| Mol.Wt. | 237.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143040 |
| CAS No | NA |
| Mol.F. | C10H13N3O3 |
| Mol.Wt. | 223.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143041 |
| CAS No | NA |
| Mol.F. | C12H15N3O4 |
| Mol.Wt. | 265.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143042 |
| CAS No | NA |
| Mol.F. | C9H10N2O2 |
| Mol.Wt. | 178.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143043 |
| CAS No | NA |
| Mol.F. | C17H24N4O6 |
| Mol.Wt. | 380.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143044 |
| CAS No | NA |
| Mol.F. | C19H22N4O4 |
| Mol.Wt. | 370.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |